Skip to content
1887

Access Microbiology open research platform logo Access Microbiology

Volume 3, Issue 3

A tale of caution: prolonged bacteraemia after probiotic use in an immunocompetent child Open Access

Abstract

as a probiotic supplement is increasingly used in both adult and paediatric patient populations. There is limited awareness about potential adverse effects.

We report a case of prolonged (111 days) bacteraemia after brief probiotic use in a 17-month-old immunocompetent child, without a definite focus of infection and in the absence of predisposing risk factors or underlying co-morbidities. We identified seven probiotic use-associated cases of prolonged bacteraemia (mean duration [range] 64 days [14–93 days] where data were available) in the literature, all with underlying co-morbidities.

probiotic preparations may cause prolonged bacteraemia, rendering patients with underlying co-morbidities as well as those with unrecognized risk factors vulnerable for significant infectious complications.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Bacillus clausii , bacteraemia and probiotic
© 2021 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000205
2021-02-24
2025-01-14
Loading full text...

Full text loading...

/deliver/fulltext/acmi/3/3/acmi000205.html?itemId=/content/journal/acmi/10.1099/acmi.0.000205&mimeType=html&fmt=ahah

References

  1. Boyle RJ, Robins-Browne RM, Tang MLK. Probiotic use in clinical practice: what are the risks?. Am J Clin Nutr 2006; 83:1256–1264 [View Article] [PubMed]
     [Google Scholar]
  2. National Institute of Health – National Center for Complementary and Integrative Health Statistics from the National Health Interview Survey. Available from: https://www.nccih.nih.gov/health/statistics-from-the-national-health-interview-survey (Accessed November 20, 2020).
  3. Abbrescia A, Palese LL, Papa S, Gaballo A, Alifano P et al. Antibiotic sensitivity of Bacillus clausii strains in commercial preparation. Clin Immunol Endocr Metab Drugs 2015; 1:102–110 [View Article]
     [Google Scholar]
  4. Ghelardi E, Celandroni F, Salvetti S, Gueye SA, Lupetti A et al. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J Appl Microbiol 2015; 119:552–559 [View Article] [PubMed]
     [Google Scholar]
  5. Ahire JJ, Kashikar MS, Madempudi RS. Survival and Germination of Bacillus clausii UBBC07 Spores in in vitro Human Gastrointestinal Tract Simulation Model and Evaluation of Clausin Production. Front Microbiol 2020; 11:1010 [View Article] [PubMed]
     [Google Scholar]
  6. Jeżewska-Frąckowiak J, Seroczynska K, Banaszczyk J, Wozniak D, Skowron M et al. Detection of endospore producing Bacillus species from commercial probiotics and their preliminary microbiological characterization. JEB 2017; 38:1435–1440 [View Article]
     [Google Scholar]
  7. Ianiro G, Rizzatti G, Plomer M, Lopetuso L, Scaldaferri F et al. Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials. Nutrients 2018; 10:E1074 [View Article] [PubMed]
     [Google Scholar]
  8. de Castro J-AA, Guno MJV-R, Perez MO. Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE). Trop Dis Travel Med Vaccines 2019; 5:14 [View Article] [PubMed]
     [Google Scholar]
  9. CLSI Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, 3rd ed. CLSI guideline M45. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
     [Google Scholar]
  10. Joshi S, Udani S, Sen S, Kirolikar S, Shetty A. Bacillus Clausii septicemia in a pediatric patient after treatment with probiotics. Pediatr Infect Dis J 2019; 38:e228–e230 [View Article] [PubMed]
     [Google Scholar]
  11. Gargar JD, Divinagracia RM. When good things go bad: a case series of bacteremia from probiotics. Chest 2019; 155:92A [View Article]
     [Google Scholar]
  12. Nacinovich F, Fernández Oses P, Sucari A et al. Probiotics in the critically ill: friends or foes? Persistent bacteriemia due to Bacillus clausii. Poster presented at: 29th European Congress of Clinical Microbiology & Infectious Diseases. Amsterdam, Netherlands: 2019 Apr 13-16
  13. Princess I, Natarajan T, Ghosh S. When good bacteria behave badly: a case report of Bacillus clausii sepsis in an immunocompetant adult. Access Microbiol 2020; 2:acmi000097 [View Article] [PubMed]
     [Google Scholar]
  14. Gueimonde M, Sánchez B, G de Los Reyes-Gavilán C, Margolles A. Antibiotic resistance in probiotic bacteria. Front Microbiol 2013; 4:202 [View Article] [PubMed]
     [Google Scholar]
  15. Enterogermina (Spores of Poly-antibiotic resistant Bacillus Clausii Origgio (VA) – Italy: Sanofi S.p.A. - Viale Europa; 202011–21040
  16. Bozdogan B, Galopin S, Leclercq R. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii. Appl Environ Microbiol 2004; 70:280–284 [View Article] [PubMed]
     [Google Scholar]
  17. Courvalin P. Antibiotic resistance: the pros and cons of probiotics. Dig Liver Dis 2006; 38 Suppl 2:S261–S265 [View Article] [PubMed]
     [Google Scholar]
  18. Senesi S, Celandroni F, Tavanti A, Ghelardi E. Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy. Appl Environ Microbiol 2001; 67:834–839 [View Article] [PubMed]
     [Google Scholar]
  19. Tewari VV, Dubey SK, Gupta G. Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial. J Trop Pediatr 2015; 61:377–385 [View Article] [PubMed]
     [Google Scholar]
  20. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006; 19:788–802 [View Article] [PubMed]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000205
Loading
A tale of caution: prolonged Bacillus clausii bacteraemia after probiotic use in an immunocompetent child
Access Microbiology 3, 000205 (2021); https://doi.org/10.1099/acmi.0.000205
/content/journal/acmi/10.1099/acmi.0.000205
/content/journal/acmi/10.1099/acmi.0.000205
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error